相关实验视频

Updated: May 6, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

对于癌症化学疗法的氧-响应型π-结合原药纳米组件

Shuwei Liu¹, Liuhui Chen¹, Hongyuan Zhang¹

¹Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

|September 27, 2025

概括

这项研究表明,通过修改具有特定π-π堆叠相互作用的前药物结构,可以优化用于癌症治疗的氧化回应纳米组件 (NA) 传递,改善瘤积累并降低毒性.

科学领域:

纳米医学是一种纳米医学.
药物运输药物运输药物运输
癌症治疗癌症治疗

背景情况:

反氧反应性前药物纳米组件 (NA) 是精确癌症治疗的关键.
π-π堆叠相互作用对NA自我组装和体内命运的影响仍然未被探索.

研究的目的:

调查 π-π 堆叠相互作用如何影响氧化还原反应性前药物的自我组装.
评估工程纳米组件的体内输送和抗瘤疗效.

主要方法:

合成了三种多克索鲁比辛 (DOX) 前药物 (FAD,FBD,FGD),具有不同的二硫化结合位置和π-结合的Fmoc部分.
在小鼠模型中特征性NA自我组装,氧化还原反应释放,稳定性,细胞吸收,药理动力学和抗瘤功效.

主要成果:

前药物结构,特别是二硫化物键的定位,决定了自我组装,反过来调节了药物释放.
FBD NAs显示出最佳的释放动力学,最小的毒性和101.7倍的瘤积累.
在4T1瘤模型中,FBD NAs显示出强大的抗瘤功效,显著降低了瘤体积.

结论:

在前药物设计中,战略的π-π堆叠相互作用优化了DOX的体内输送-释放平衡.
这种方法可以提高抗瘤疗效,同时最大限度地降低全身毒性,从而改善癌症治疗.

关键词:

德克索鲁比辛是一种前药物.药物输送是药物输送的过程.药物释放释放药物释放药物释放的时间分子设计分子设计.纳米组装的纳米组件

更多相关视频

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...